نتایج جستجو برای: psa ratio

تعداد نتایج: 512949  

Journal: :Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005
Ping Zhou Ming-Hui Chen David McLeod Peter R Carroll Judd W Moul Anthony V D'Amico

PURPOSE We evaluated predictors of prostate cancer-specific mortality (PCSM) after prostate-specific antigen (PSA) failure after radical prostatectomy (RP) or radiation therapy (RT). PATIENTS AND METHODS A total of 1,159 men with clinically localized prostate cancer treated with RP (n = 498) or RT (n = 661) developed PSA failure, and they formed the study cohort. Competing risk regression ana...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2003
Jonathan P Dyke Kristen L Zakian William M Spees Cornelia Matei Yuchen Chen Xiangling Mao Dikoma C Shungu Jason A Koutcher

PURPOSE The ability to determine the spatial and metabolic distribution of prostate cancer is essential in assessing initial stage, prognosis, and treatment efficacy. Current markers of tumor progression such as prostate-specific antigen (PSA) do not provide spatial information about tumor extent or regions of high metabolic activity. EXPERIMENTAL DESIGN This study used the androgen-dependent...

2014
Jae Hyun Ahn Jeong Zoo Lee Moon Kee Chung Hong Koo Ha

Although prostate-specific antigen (PSA) is a very useful screening tool, prostate biopsy is still necessary to confirm prostate cancer (PCA). However, it is reported that PSA is associated with a high false-positive rate and prostate biopsy also has various procedure-related complications. Therefore, the authors have devised a nomogram, which can be used to estimate the risk of PCA, using avai...

Journal: :Annals of oncology : official journal of the European Society for Medical Oncology 2007
S Oudard E Banu F Scotte A Banu J Medioni P Beuzeboc F Joly J-M Ferrero F Goldwasser J-M Andrieu

BACKGROUND We evaluated the possible use of prostate-specific antigen doubling time (PSA-DT) before chemotherapy initiation as a surrogate marker of survival in hormone-refractory prostate cancer (HRPC) patients. PATIENTS AND METHODS Data from 250 consecutive metastatic HRPC patients treated with chemotherapy between February 2000 and November 2006 were retrospectively analysed. At least thre...

2015
Han-Min Wei Hai-Tao Chen Ping Wang Yi-Shuo Wu Rong Na Fang Liu Ji-Shan Sun De-Ke Jiang Da-Ru Lu Jianfeng Xu

collected for each patient before biopsy. The study was approved by the Institutional Ethics Review Board at Huashan Hospital and written informed consent was completed for each patient. Because the Hologic PCA3 kit is not currently available in China, urine PCA3 RNA level was measured using an in-house qPCR method and its level was normalized by urine levels of PSA mRNA. PCA3 level was calcula...

2003
Jonathan P. Dyke Kristen L. Zakian William M. Spees Cornelia Matei Yuchen Chen Xiangling Mao Dikoma C. Shungu Jason A. Koutcher

Purpose: The ability to determine the spatial and metabolic distribution of prostate cancer is essential in assessing initial stage, prognosis, and treatment efficacy. Current markers of tumor progression such as prostate-specific antigen (PSA) do not provide spatial information about tumor extent or regions of high metabolic activity. Experimental Design: This study used the androgendependent ...

2015
Aldiouma Diallo Samba O. Sow Olubukola T. Idoko Siddhivinayak Hirve Helen Findlow Marie-Pierre Preziosi Cheryl Elie Prasad S. Kulkarni Varsha Parulekar Bou Diarra Fadima Cheick Haidara Fatoumata Diallo Milagritos Tapia Adebayo K. Akinsola Richard A. Adegbola Ashish Bavdekar Sanjay Juvekar Julie Chaumont Lionel Martellet Elisa Marchetti Marc F. LaForce Brian D. Plikaytis Godwin C. Enwere Yuxiao Tang Ray Borrow George Carlone Simonetta Viviani

BACKGROUND Mass vaccination campaigns of the population aged 1-29 years with 1 dose of group A meningococcal (MenA) conjugate vaccine (PsA-TT, MenAfriVac) in African meningitis belt countries has resulted in the near-disappearance of MenA. The vaccine was tested in clinical trials in Africa and in India and found to be safe and highly immunogenic compared with the group A component of the licen...

2014
Shyam K. Tanguturi Ming-Hui Chen Marian Loffredo Jerome P. Richie Anthony V. D'Amico

Purpose. We investigated whether NS-RP increased risk of PSA failure and whether PSA should be included as a selection criterion for NS. Methods. We evaluated 357 consecutive men with screen-detected PC who underwent open RP without adjuvant radiotherapy between 9/11/2001 and 12/30/2008. Criteria for NS included Gleason score ≤3 + 4, percentage of positive biopsies (PPB) ≤50%, percentage of cor...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید